Lyerly HK - Search Results

1

Morse MA, Lyerly HK, Clay TM, Abdel-Wahab O, Chui SY, Garst J, Gollob J, Grossi PM, Kalady M, Mosca PJ, Onaitis M, Sampson JH, Seigler HF, Toloza EM, Tyler D, Vieweg J, Yang Y. Morse MA, et al. Among authors: lyerly hk. Curr Probl Surg. 2004 Jan;41(1):15-132. doi: 10.1016/S0011384003001321. Curr Probl Surg. 2004. PMID: 14749625 Review. No abstract available.

2

Measurement of direct and indirect forms of anti-HIV-1 ADCC: implications for other retroviral disease.

Weinhold KJ, Tyler DS, Lyerly HK. Weinhold KJ, et al. Among authors: lyerly hk. Dev Biol Stand. 1990;72:343-8. Dev Biol Stand. 1990. PMID: 2282991

3

Alterations in antibody-dependent cellular cytotoxicity during the course of HIV-1 infection. Humoral and cellular defects.

Tyler DS, Stanley SD, Nastala CA, Austin AA, Bartlett JA, Stine KC, Lyerly HK, Bolognesi DP, Weinhold KJ. Tyler DS, et al. Among authors: lyerly hk. J Immunol. 1990 May 1;144(9):3375-84. J Immunol. 1990. PMID: 2329275

4

GP120 specific cellular cytotoxicity in HIV-1 seropositive individuals. Evidence for circulating CD16+ effector cells armed in vivo with cytophilic antibody.

Tyler DS, Nastala CL, Stanley SD, Matthews TJ, Lyerly HK, Bolognesi DP, Weinhold KJ. Tyler DS, et al. Among authors: lyerly hk. J Immunol. 1989 Feb 15;142(4):1177-82. J Immunol. 1989. PMID: 2536767

5

Anti-HIV-1 ADCC.

Tyler DS, Lyerly HK, Weinhold KJ. Tyler DS, et al. Among authors: lyerly hk. AIDS Res Hum Retroviruses. 1989 Dec;5(6):557-63. doi: 10.1089/aid.1989.5.557. AIDS Res Hum Retroviruses. 1989. PMID: 2692657 Review. No abstract available.

6

Cellular anti-GP120 cytolytic reactivities in HIV-1 seropositive individuals.

Weinhold KJ, Lyerly HK, Matthews TJ, Tyler DS, Ahearne PM, Stine KC, Langlois AJ, Durack DT, Bolognesi DP. Weinhold KJ, et al. Among authors: lyerly hk. Lancet. 1988 Apr 23;1(8591):902-5. doi: 10.1016/s0140-6736(88)91713-8. Lancet. 1988. PMID: 2895830

7

Immunotherapy of cancer using cytokine gene-modified tumor vaccines.

Gilboa E, Lyerly HK, Vieweg J, Saito S. Gilboa E, et al. Among authors: lyerly hk. Semin Cancer Biol. 1994 Dec;5(6):409-17. Semin Cancer Biol. 1994. PMID: 7703440 Review.

8

Active immunotherapy of pancreatic cancer with tumor cells genetically engineered to secrete multiple cytokines.

Clary BM, Coveney EC, Blazer DG 3rd, Philip R, Lyerly HK. Clary BM, et al. Among authors: lyerly hk. Surgery. 1996 Aug;120(2):174-81. doi: 10.1016/s0039-6060(96)80285-6. Surgery. 1996. PMID: 8751580

9

Inhibition of established pancreatic cancers following specific active immunotherapy with interleukin-2 gene-transduced tumor cells.

Clary BM, Coveney EC, Philip R, Blazer DG 3rd, Morse M, Gilboa E, Lyerly HK. Clary BM, et al. Among authors: lyerly hk. Cancer Gene Ther. 1997 Mar-Apr;4(2):97-104. Cancer Gene Ther. 1997. PMID: 9080118

10

Active immunization with tumor cells transduced by a novel AAV plasmid-based gene delivery system.

Clary BM, Coveney EC, Blazer DG 3rd, Philip R, Philip M, Morse M, Gilboa E, Lyerly HK. Clary BM, et al. Among authors: lyerly hk. J Immunother. 1997 Jan;20(1):26-37. doi: 10.1097/00002371-199701000-00003. J Immunother. 1997. PMID: 9101411

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

304 results

Search Page